Corient Ia LLC Natera, Inc. Transaction History
Corient Ia LLC
- $141 Billion
- Q1 2025
A detailed history of Corient Ia LLC transactions in Natera, Inc. stock. As of the latest transaction made, Corient Ia LLC holds 2,000 shares of NTRA stock, worth $314,760. This represents 0.2% of its overall portfolio holdings.
Number of Shares
2,000Holding current value
$314,760% of portfolio
0.2%Shares
1 transactions
Others Institutions Holding NTRA
# of Institutions
663Shares Held
124MCall Options Held
971KPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA12.4MShares$1.95 Billion0.03% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.16 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.07 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.74MShares$1.06 Billion0.12% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.43MShares$697 Million3.74% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $15.3B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...